Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study

Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study

<p>Abstract</p> <p>Background</p> <p>Little is known concerning the degree to which initiation of sildenafil for pulmonary arterial hypertension (PAH) impacts patterns of healthcare utilization and costs.</p> <p>Methods</p> <p>Using a large US he...

Full description

Bibliographic Details
Main Authors: Berger Ariel, Edelsberg John, Teal Simon, Mychaskiw Marko A, Oster Gerry
Format: Article
Language:English
Published: BMC 2012-12-01
Series:BMC Pulmonary Medicine
Subjects:
Pulmonary arterial hypertension
Primary pulmonary hypertension
Sildenafil
PDE5, Phosphodiesterase type 5
Health expenditure
Utilization
Online Access:http://www.biomedcentral.com/1471-2466/12/75

Internet

http://www.biomedcentral.com/1471-2466/12/75

Similar Items